Inside the study for a remedy to fight Congo's deadliest Ebola outbreak

• The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment.
• The trial began in July and is one of several studies launched to find some protection and another way of at least slowing the outbreak.
• The Associated Press spoke this week to partici